Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
Clinical trial NCT05828381 · UNKNOWN
Trial details
- NCT number
- NCT05828381
- Sponsor
- Fujian Medical University Union Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.